| Ofatumumab versus Teriflunomide in Multiple Sclerosis AIAIIT Groups N Engl J Med 383 (6), 546-557, 2020 | 689* | 2020 |
| Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus–myoclonus L Bataller, F Graus, A Saiz, JJ Vilchez Brain 124 (2), 437-443, 2001 | 481 | 2001 |
| Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas:¿ una pandemia demorada? PJ Serrano-Castro, G Estivill-Torrús, P Cabezudo-García, ... Neurología 35 (4), 245-251, 2020 | 282* | 2020 |
| Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. F Gomez-Aranda, F Canadillas, JF Marti-Masso, E Diez-Tejedor, ... Brain 120 (7), 1105-1113, 1997 | 224 | 1997 |
| Miller‐Fisher syndrome after SARS‐CoV‐2 infection JA Reyes‐Bueno, L García‐Trujillo, P Urbaneja, NL Ciano‐Petersen, ... European journal of neurology 27 (9), 1759-1761, 2020 | 126 | 2020 |
| International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines CN Dodd, SA Romio, S Black, C Vellozzi, N Andrews, M Sturkenboom, ... Vaccine 31 (40), 4448-4458, 2013 | 114 | 2013 |
| Incidence and case fatality rate of COVID-19 in patients with active epilepsy P Cabezudo-García, NL Ciano-Petersen, N Mena-Vázquez, G Pons-Pons, ... Neurology 95 (10), e1417-e1425, 2020 | 113 | 2020 |
| The biomedical uses of inositols: A nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases AJ López-Gambero, C Sanjuan, PJ Serrano-Castro, J Suárez, ... Biomedicines 8 (9), 295, 2020 | 93 | 2020 |
| Antiepileptic treatment in patients with epilepsy and other comorbidities J Ruiz-Giménez, JC Sánchez-Alvarez, F Cañadillas-Hidalgo, ... Seizure 19 (7), 375-382, 2010 | 90 | 2010 |
| Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review P Serrano, N Hernández, JA Arroyo, JM Llobet Clinical Infectious Diseases 44 (6), e57-e61, 2007 | 86 | 2007 |
| Adult prevalence of epilepsy in Spain: EPIBERIA, a Population‐Based Study PJ Serrano-Castro, JA Mauri-Llerda, FJ Hernández-Ramos, ... The Scientific World Journal 2015 (1), 602710, 2015 | 77 | 2015 |
| Response to immunotherapy in anti‐IgLON5 disease: a systematic review P Cabezudo‐García, N Mena‐Vázquez, G Estivill Torrus, ... Acta Neurologica Scandinavica 141 (4), 263-270, 2020 | 74 | 2020 |
| The gap between dyslipidemia control perceived by physicians and objective control patterns in Spain JR Banegas, O Vegazo, P Serrano, E Luengo, T Mantilla, R Fernández, ... Atherosclerosis 188 (2), 420-424, 2006 | 74 | 2006 |
| Spatial navigation impairment in patients with refractory temporal lobe epilepsy: evidence from a new virtual reality-based task R Cánovas, I León, P Serrano, MD Roldán, JM Cimadevilla Epilepsy & Behavior 22 (2), 364-369, 2011 | 72 | 2011 |
| Epilepsia refractaria del adulto JC Sánchez-Álvarez, PJ Serrano-Castro, F Cañadillas-Hidalgo Rev Neurol 35 (10), 931-935, 2002 | 69* | 2002 |
| Lipid‐specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with … LM Villar, L Costa‐Frossard, T Masterman, O Fernandez, X Montalban, ... Annals of neurology 77 (3), 447-457, 2015 | 66 | 2015 |
| The cognitive and psychiatric subacute impairment in severe Covid-19 PJ Serrano-Castro, FJ Garzón-Maldonado, I Casado-Naranjo, ... Scientific reports 12 (1), 3563, 2022 | 52 | 2022 |
| Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide V Villanueva, FJ López, JM Serratosa, B González-Giraldez, D Campos, ... Epilepsy & Behavior 29 (2), 349-356, 2013 | 52 | 2013 |
| Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: outcomes from an expanded access program V Villanueva, D Santos‐Carrasco, P Cabezudo‐García, A Gómez‐Ibáñez, ... Epilepsia open 8 (3), 918-929, 2023 | 51 | 2023 |
| Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: a multicentre open-label trial WW Zadeh, A Escartin, W Byrnes, F Tennigkeit, S Borghs, T Li, ... Seizure 31, 72-79, 2015 | 51 | 2015 |
Estivill-Torrús GuillermoHospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de MálagaVerified email at ibima.eu
